Peter L. Hoang's most recent trade in Marker Therapeutics Inc was a trade of 199,094 Common Stock done . Disclosure was reported to the exchange on March 24, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Marker Therapeutics Inc | Peter L. Hoang | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2022 | 199,094 | 531,662 (1%) | 0% | 0 | Common Stock | |
| Marker Therapeutics Inc | Peter L. Hoang | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.48 per share. | 24 Mar 2022 | 48,376 | 483,286 (1%) | 0% | 0.5 | 23,453 | Common Stock |
| Marker Therapeutics Inc | Peter L. Hoang | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 430,000 | 430,000 | - | - | Employee Stock Option (right to buy) | |
| Marker Therapeutics Inc | Peter L. Hoang | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.75 per share. | 16 Mar 2021 | 142,857 | 332,568 (0%) | 0% | 1.8 | 250,000 | Common Stock |
| Marker Therapeutics Inc | Peter L. Hoang | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 430,000 | 430,000 | - | - | Employee Stock Option (right to buy) |